10.05.2017 - French pharma company Sanofi has signed a research collaboration and license option agreement with Scottish drug design company Exscientia that focuses on metabolic diseases such...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)